Unknown NA INTERVENTIONAL 2-arm NCT03525028

A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis

Multicenter, Randomized, Controlled Clinical Trial Research Evaluating the Use of Combination Therapy of Glucocorticoids and Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis

Sponsor: Peking Union Medical College Hospital

Conditions Glucocorticoid Metformin Uveitis

Interventions Metformin Placebo

Updated 8 times since 2018 Last updated: May 5, 2022 Started: Nov 1, 2018 Primary completion: Jan 1, 2023 Completion: Jan 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Glucocorticoid and Metformin, this trial is ongoing. The trial is conducted by Peking Union Medical College Hospital and has accumulated 8 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jun 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2022 — Jun 2024 [monthly]

Recruiting NA
May 2021 — Jun 2022 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Jan 2021 — May 2021 [monthly]

Recruiting NA
Oct 2019 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Oct 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Peking Union Medical College Hospital
Peking University First Hospital
Tianjin Medical University
Zhongshan Ophthalmic Center, Sun Yat-sen University

Data source: Tianjin Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tianjin, China